Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of body mass index elevation, Vitamin D receptor polymorphisms and antipsychotics on the risk of Vitamin D deficiency in schizophrenia patients.

Journal of psychiatric research - 1 Jul 2024

Goh Xue Xin, Tee Shiau Foon, Tang Pek Yee, Chee Kok Yoon, Loh Kenny Kien Woon

Abstract excerpt

Antipsychotics with weight gain as side effect and vitamin D receptor dysfunction associated with single nucleotide polymorphisms (VDR SNPs) may have different effects on vitamin D status. Hence, present study aimed to investigate the relationship between vitamin D with body mass index (BMI), antipsychotics and VDR SNPs (rs2228570, rs1544410, rs7975232 and rs731236) in Malaysian patients with schizophrenia. Serum...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Body Mass Index
Share to Malaysia
Share to Polymorphism, Single Nucleotide
Share to Receptors, Calcitriol
Share to Schizophrenia
Share to Vitamin D
Share to Vitamin D Deficiency

Source

Identifiers

PMID: 38761517
DOI: 10.1016/j.jpsychires.2024.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of body mass index elevation, Vitamin D receptor polymorphisms and antipsychotics on the risk of Vitamin D deficiency in schizophrenia patients.PMID 38761517Read ↗

Vitamin D Deficiency as a Risk Factor for Schizophrenia: A meta-analysis of Observational StudiesSemantic proximity Read ↗

Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures.Semantic proximity Read ↗

D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density.Semantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.Semantic proximity Read ↗

The association between body mass index elevation and differentiation in vitamin D receptor gene expression, genetic polymorphism, and oxidative stress in adult Egyptian individuals.Semantic proximity Read ↗

The causal effect of schizophrenia on fractures and bone mineral density: a comprehensive two-sample Mendelian randomization study of European ancestrySemantic proximity Read ↗

Relevance of Diet in Schizophrenia: Focusing on Prenatal Nutritional Deficiency, Obesity, Oxidative Stress and InflammationSemantic proximity Read ↗

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity Read ↗

Relationship between Vitamin D3 Deficiency, Metabolic Syndrome and VDR, GC, and CYP2R1 Gene PolymorphismsSemantic proximity Read ↗

Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophreniaSemantic proximity Read ↗

Effect of Genetic Variants, Gender, and Co-treatment on Olanzapine Plasma Concentration in Chinese patients with schizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.